Clinical implications of TP53 mutations/allelic state in patients (Pts) with myelodysplastic syndromes/neoplasms (MDS) treated with hypomethylating agents (HMA)- a multicenter, retrospective analysis from the VALIDATE database Meeting Abstract
| Authors: | Kewan, T.; Bewersdorf, J. P.; Blaha, O.; Stahl, M.; Al Ali, N. H.; DeZern, A. E.; Sekeres, M. A.; Carraway, H. E.; Desai, P.; Griffiths, E. A.; Stein, E. M.; Brunner, A. M.; Amaya, M. L.; Zeidner, J. F.; Savona, M. R.; Stempel, J. M.; Chandhok, N. S.; Cochran, H.; Ramaswamy, R.; Singh, A.; Roboz, G. J.; Rolles, B.; Wang, E. S.; Harris, A. C.; Shallis, R. M.; Xie, Z. E.; Padron, E.; Maciejewski, J. P.; Della Porta, M. G.; Komrokji, R. S.; Sallman, D. A.; Zeidan, A. M. |
| Abstract Title: | Clinical implications of TP53 mutations/allelic state in patients (Pts) with myelodysplastic syndromes/neoplasms (MDS) treated with hypomethylating agents (HMA)- a multicenter, retrospective analysis from the VALIDATE database |
| Meeting Title: | 65th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 142 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2023 Dec 9-12 |
| Meeting Location: | San Deigo, CA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2023-11-02 |
| Start Page: | 1002 |
| Language: | English |
| ACCESSION: | WOS:001159306704026 |
| DOI: | 10.1182/blood-2023-186875 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract -- Source: Wos |
